First case of drug eruption due to ipragliflozin: Case report and review of the literature.-临床诊疗知识库

First case of drug eruption due to ipragliflozin: Case report and review of the literature.

| 浏览：25

作者：

Natsuko, Saito-Sasaki；Yu, Sawada；Daisuke, Nishio；Motonobu, Nakamura

来源：

The Australasian journal of dermatology 2016 年

标签：

SGLT2 inhibitor case report drug eruption ipragliflozin literature review

Ipragliflozin is a new drug for the treatment of diabetes mellitus. Its action of sodium-glucose cotransporter 2 (SGLT2) inhibition induces glucosuria and decreases blood glucose levels. We report the first case of ipragliflozin-related eczematous drug eruption and a review of the past literature on drug eruptions caused by SGLT2 inhibitors.

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求，方便快速、便捷的获取实用的医学信息，辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍

临床诊疗知识库现支持机构用户及个人包时用户开通服务。如需开通机构账号，请机构管理员联系我们，联系电话：010-58882667；个人包时开通请直接点击“个人包时订购”，开通后即可使用。

相似文献